Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C16168> ?p ?o ?g. }
Showing items 1 to 18 of
18
with 100 items per page.
- NCIT_C16168 IAO_0000115 "Originally, therapeutic administration of serum or gamma globulin containing preformed antibodies produced by another individual; currently, immunotherapy includes nonspecific systemic stimulation, adjuvants, active specific immunotherapy, and adoptive immunotherapy. New forms of immunotherapy include the use of monoclonal antibodies. This approach has been widely adopted by cancer specialists, often in cases which fail to respond to other treatment. Immunotherapy aims to boost immune system function, as with the administration of interferons and interleukin-2, or to attack cancerous cells directly, as with the injection of monoclonal antibodies. Various immunotherapeutic techniques have also been employed among AIDS patients. In addition, a number of alternative medical practices are claimed to enhance immune function, and various over-the-counter substances (e.g., goldenseal, lysine have gained popularity for this supposed property." @default.
- NCIT_C16168 NCIT_NHC0 "C16168" @default.
- NCIT_C16168 NCIT_P106 "Clinical Attribute" @default.
- NCIT_C16168 NCIT_P108 "Prior Immunotherapy" @default.
- NCIT_C16168 NCIT_P207 "C1514461" @default.
- NCIT_C16168 NCIT_P366 "Prior_Immunotherapy" @default.
- NCIT_C16168 normalizedInformationContent "95.413332725061409" @default.
- NCIT_C16168 referenceCount "2" @default.
- NCIT_C16168 hasExactSynonym "Prior Immunotherapy" @default.
- NCIT_C16168 type Class @default.
- NCIT_C16168 isDefinedBy ncit.owl @default.
- NCIT_C16168 label "Prior Immunotherapy" @default.
- NCIT_C16168 subClassOf NCIT_C16124 @default.
- NCIT_C16168 subClassOf NCIT_C16168 @default.
- NCIT_C16168 subClassOf NCIT_C16203 @default.
- NCIT_C16168 subClassOf NCIT_C25218 @default.
- NCIT_C16168 subClassOf NCIT_C43431 @default.
- NCIT_C16168 subClassOf NCIT_C49236 @default.